Kintegral Advisory’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.36M | Hold |
61,479
| – | – | 0.52% | 44 |
|
|
2026
Q1 | $4.42M | Sell |
61,479
-2,726
| -4% | -$210K | 0.42% | 59 |
|
|
2025
Q4 | $5.1M | Sell |
64,205
-1,757
| -3% | -$139K | 0.43% | 63 |
|
|
2025
Q3 | $4.97M | Sell |
65,962
-295
| -0.4% | -$20.2K | 0.42% | 67 |
|
|
2025
Q2 | $4.57M | Sell |
66,257
-100
| -0.2% | -$6.56K | 0.42% | 69 |
|
|
2025
Q1 | $4.5M | Sell |
66,357
-224
| -0.3% | -$13.4K | 0.45% | 69 |
|
|
2024
Q4 | $2.99M | Sell |
66,581
-3,101
| -4% | -$174K | 0.28% | 95 |
|
|
2024
Q3 | $4.38M | Sell |
69,682
-913
| -1% | -$53.3K | 0.4% | 76 |
|
|
2024
Q2 | $4.17M | Buy |
70,595
+37,670
| +114% | +$2.36M | 0.4% | 77 |
|
|
2024
Q1 | $2.63M | Sell |
32,925
-103
| -0.3% | -$7.87K | 0.26% | 99 |
|
|
2023
Q4 | $2.61M | Sell |
33,028
-210
| -0.6% | -$14.9K | 0.29% | 97 |
|
|
2023
Q3 | $2.32M | Sell |
33,238
-20
| -0.1% | -$1.42K | 0.29% | 96 |
|
|
2023
Q2 | $2.3M | Hold |
33,258
| – | – | 0.27% | 100 |
|
|
2023
Q1 | $2.47M | Sell |
33,258
-1,787
| -5% | -$150K | 0.32% | 95 |
|
|
2022
Q4 | $3.27M | Buy |
35,045
+20,079
| +134% | +$1.94M | 0.43% | 77 |
|
|
2022
Q3 | $1.43M | Hold |
14,966
| – | – | 0.2% | 122 |
|
|
2022
Q2 | $1.39M | Buy |
14,966
+317
| +2% | +$30.9K | 0.18% | 125 |
|
|
2022
Q1 | $1.48M | Buy |
14,649
+328
| +2% | +$34.5K | 0.16% | 130 |
|
|
2021
Q4 | $1.48M | Hold |
14,321
| – | – | 0.15% | 131 |
|
|
2021
Q3 | $1.22M | Hold |
14,321
| – | – | 0.14% | 134 |
|
|
2021
Q2 | $1.2M | Hold |
14,321
| – | – | 0.14% | 136 |
|
|
2021
Q1 | $1.08M | Hold |
14,321
| – | – | 0.14% | 139 |
|
|
2020
Q4 | $978K | Hold |
14,321
| – | – | 0.13% | 144 |
|
|
2020
Q3 | $836K | Sell |
14,321
-461
| -3% | -$28.7K | 0.13% | 141 |
|
|
2020
Q2 | $960K | Hold |
14,782
| – | – | 0.15% | 131 |
|
|
2020
Q1 | $877K | Buy |
14,782
+1,653
| +13% | +$110K | 0.17% | 130 |
|
|
2019
Q4 | $975K | Hold |
13,129
| – | – | 0.18% | 135 |
|
|
2019
Q3 | $828K | Hold |
13,129
| – | – | 0.16% | 141 |
|
|
2019
Q2 | $715K | Hold |
13,129
| – | – | 0.14% | 148 |
|
|
2019
Q1 | $708K | Sell |
13,129
-70
| -0.5% | -$4.32K | 0.15% | 144 |
|
|
2018
Q4 | $865K | Buy |
+13,199
| New | +$985K | 0.26% | 92 |
|
Other funds holding CVS
Kintegral Advisory's CVS Position: Q2 2026 in Review
Kintegral Advisory held its CVS Health (CVS) position steady in Q2 2026 at 61,479 shares worth $6.36M. The position accounts for 0.52% of the portfolio, ranked #44.
Kintegral Advisory first reported a position in CVS in Q4 2018 and has held it in 31 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Kintegral Advisory held 61,479 shares of CVS Health worth $6.36M as of Q2 2026.
- Kintegral Advisory left its CVS Health share count unchanged in Q2 2026.
- CVS Health made up 0.52% of Kintegral Advisory's portfolio in Q2 2026, its #44 holding.
- Kintegral Advisory first reported a position in CVS Health in Q4 2018 and has held it in 31 quarters since.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Kintegral Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.